☰

Russell S. Dahl, Ph.D. - Publications

Affiliations: 
2004 University of California, San Diego, La Jolla, CA 
Area:
Organic Chemistry
Tree Info Similar researchers PubMed Report error

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Krajnak K, Dahl R. Small molecule SUMOylation activators are novel neuroprotective agents. Bioorganic & Medicinal Chemistry Letters. PMID 29269215 DOI: 10.1016/J.Bmcl.2017.12.028  0.302
2015 Musumeci L, Kuijpers MJ, Gilio K, Hego A, Théâtre E, Maurissen L, Vandereyken M, Diogo CV, Lecut C, Guilmain W, Bobkova EV, Eble JA, Dahl R, Drion P, Rascon J, et al. Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis. Circulation. 131: 656-68. PMID 25520375 DOI: 10.1161/Circulationaha.114.010186  0.302
2014 Bravo Y, Teriete P, Dhanya RP, Dahl R, Lee PS, Kiffer-Moreira T, Ganji SR, Sergienko E, Smith LH, Farquharson C, Millán JL, Cosford ND. Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1. Bioorganic & Medicinal Chemistry Letters. 24: 4308-11. PMID 25124115 DOI: 10.1016/J.Bmcl.2014.07.013  0.401
2014 Dhanya RP, Sheffler DJ, Dahl R, Davis M, Lee PS, Yang L, Nickols HH, Cho HP, Smith LH, D'Souza MS, Conn PJ, Der-Avakian A, Markou A, Cosford ND. Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence. Journal of Medicinal Chemistry. 57: 4154-72. PMID 24735492 DOI: 10.1021/Jm5000563  0.354
2014 Barile E, Wang S, Das SK, Noberini R, Dahl R, Stebbins JL, Pasquale EB, Fisher PB, Pellecchia M. Design, synthesis and bioevaluation of an EphA2 receptor-based targeted delivery system. Chemmedchem. 9: 1403-12. PMID 24677792 DOI: 10.1002/Cmdc.201400067  0.3
2014 Gruber SJ, Cornea RL, Li J, Peterson KC, Schaaf TM, Gillispie GD, Dahl R, Zsebo KM, Robia SL, Thomas DD. Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells. Journal of Biomolecular Screening. 19: 215-22. PMID 24436077 DOI: 10.1016/J.Bpj.2013.11.2409  0.333
2014 Ardecky RJ, Bobkova EV, Kiffer-Moreira T, Brown B, Ganji S, Zou J, Pass I, Narisawa S, Iano FG, Rosenstein C, Cheltsov A, Rascon J, Hedrick M, Gasior C, Forster A, ... ... Dahl R, et al. Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymes. Bioorganic & Medicinal Chemistry Letters. 24: 1000-4. PMID 24412070 DOI: 10.1016/J.Bmcl.2013.12.043  0.328
2013 Cornea RL, Gruber SJ, Lockamy EL, Muretta JM, Jin D, Chen J, Dahl R, Bartfai T, Zsebo KM, Gillispie GD, Thomas DD. High-throughput FRET assay yields allosteric SERCA activators. Journal of Biomolecular Screening. 18: 97-107. PMID 22923787 DOI: 10.1177/1087057112456878  0.323
2013 Kiffer-Moreira T, Yadav MC, Zhu D, Narisawa S, Sheen C, Stec B, Cosford ND, Dahl R, Farquharson C, Hoylaerts MF, MacRae VE, Millán JL. Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification Journal of Bone and Mineral Research. 28: 81-91. PMID 22887744 DOI: 10.1002/Jbmr.1733  0.311
2012 Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND. Orally active metabotropic glutamate subtype 2 receptor positive allosteric modulators: structure-activity relationships and assessment in a rat model of nicotine dependence. Journal of Medicinal Chemistry. 55: 9434-45. PMID 23009245 DOI: 10.1021/Jm3005306  0.352
2012 Toth JI, Yang L, Dahl R, Petroski MD. A gatekeeper residue for NEDD8-activating enzyme inhibition by MLN4924. Cell Reports. 1: 309-16. PMID 22832224 DOI: 10.1016/J.Celrep.2012.02.006  0.329
2012 Vang T, Liu WH, Delacroix L, Wu S, Vasile S, Dahl R, Yang L, Musumeci L, Francis D, Landskron J, Tasken K, Tremblay ML, Lie BA, Page R, Mustelin T, et al. LYP inhibits T-cell activation when dissociated from CSK. Nature Chemical Biology. 8: 437-46. PMID 22426112 DOI: 10.1038/Nchembio.916  0.319
2012 Wang S, Placzek WJ, Stebbins JL, Mitra S, Noberini R, Koolpe M, Zhang Z, Dahl R, Pasquale EB, Pellecchia M. Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells. Journal of Medicinal Chemistry. 55: 2427-36. PMID 22329578 DOI: 10.1021/Jm201743S  0.311
2012 Zhai D, Godoi P, Sergienko E, Dahl R, Chan X, Brown B, Rascon J, Hurder A, Su Y, Chung TD, Jin C, Diaz P, Reed JC. High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic Bcl-2 family member Bfl-1. Journal of Biomolecular Screening. 17: 350-60. PMID 22156224 DOI: 10.1177/1087057111429372  0.393
2012 Sergienko E, Xu J, Liu WH, Dahl R, Critton DA, Su Y, Brown BT, Chan X, Yang L, Bobkova EV, Vasile S, Yuan H, Rascon J, Colayco S, Sidique S, et al. Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation. Acs Chemical Biology. 7: 367-77. PMID 22070201 DOI: 10.1021/Cb2004274  0.407
2011 Wei J, Stebbins JL, Kitada S, Dash R, Zhai D, Placzek WJ, Wu B, Rega MF, Zhang Z, Barile E, Yang L, Dahl R, Fisher PB, Reed JC, Pellecchia M. An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins. Frontiers in Oncology. 1: 28. PMID 22655238 DOI: 10.3389/Fonc.2011.00028  0.353
2011 Dahl R, Bravo Y, Sharma V, Ichikawa M, Dhanya RP, Hedrick M, Brown B, Rascon J, Vicchiarelli M, Mangravita-Novo A, Yang L, Stonich D, Su Y, Smith LH, Sergienko E, et al. Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia. Journal of Medicinal Chemistry. 54: 3661-8. PMID 21539312 DOI: 10.1021/Jm101401A  0.403
2011 Bobkova EV, Liu WH, Colayco S, Rascon J, Vasile S, Gasior C, Critton DA, Chan X, Dahl R, Su Y, Sergienko E, Chung TD, Mustelin T, Page R, Tautz L. Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids. Acs Medicinal Chemistry Letters. 2: 113-118. PMID 21503265 DOI: 10.1021/Ml100103P  0.394
2011 De SK, Barile E, Chen V, Stebbins JL, Cellitti JF, Machleidt T, Carlson CB, Yang L, Dahl R, Pellecchia M. Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase. Bioorganic & Medicinal Chemistry. 19: 2582-8. PMID 21458276 DOI: 10.1016/J.Bmc.2011.03.017  0.403
2011 Stanford SM, Krishnamurthy D, Falk MD, Messina R, Debnath B, Li S, Liu T, Kazemi R, Dahl R, He Y, Yu X, Chan AC, Zhang ZY, Barrios AM, Woods VL, et al. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. Journal of Medicinal Chemistry. 54: 1640-54. PMID 21341673 DOI: 10.1021/Jm101202J  0.302
2011 Barile E, De S, Carlson CB, Chen V, Knutzen C, Riel-Mehan M, Dahl R, Chiang G, Pellecchia M. Abstract 3834: 3-ethynyl-1H-indazoles as inhibitors of PI3k signaling pathway Cancer Research. 71: 3834-3834. DOI: 10.1158/1538-7445.Am2011-3834  0.426
2010 Barile E, De SK, Carlson CB, Chen V, Knutzen C, Riel-Mehan M, Yang L, Dahl R, Chiang G, Pellecchia M. Design, synthesis, and structure-activity relationships of 3-ethynyl-1H-indazoles as inhibitors of the phosphatidylinositol 3-kinase signaling pathway. Journal of Medicinal Chemistry. 53: 8368-75. PMID 21062009 DOI: 10.1021/Jm100825H  0.436
2010 Wei J, Kitada S, Stebbins JL, Placzek W, Zhai D, Wu B, Rega MF, Zhang Z, Cellitti J, Yang L, Dahl R, Reed JC, Pellecchia M. Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. Journal of Medicinal Chemistry. 53: 8000-11. PMID 21033669 DOI: 10.1021/Jm100746Q  0.384
2010 Cashman JR, MacDonald M, Ghirmai S, Okolotowicz KJ, Sergienko E, Brown B, Garcia X, Zhai D, Dahl R, Reed JC. Inhibition of Bfl-1 with N-aryl maleimides. Bioorganic & Medicinal Chemistry Letters. 20: 6560-4. PMID 20933419 DOI: 10.1016/J.Bmcl.2010.09.046  0.393
2010 Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R, Dalesandro D, Delaet NG, Erb E, Ernst JT, Gibbs A, Kahl J, Kessler L, Kucharski J, Lum C, Lundström J, et al. Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site. Bioorganic & Medicinal Chemistry Letters. 20: 4819-24. PMID 20663667 DOI: 10.1016/J.Bmcl.2010.06.102  0.348
2010 Wei J, Stebbins JL, Kitada S, Dash R, Placzek W, Rega MF, Wu B, Cellitti J, Zhai D, Yang L, Dahl R, Fisher PB, Reed JC, Pellecchia M. BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. Journal of Medicinal Chemistry. 53: 4166-76. PMID 20443627 DOI: 10.1021/Jm1001265  0.397
2010 Shi R, Re D, Dudl E, Cuddy M, Okolotowicz KJ, Dahl R, Su Y, Hurder A, Kitada S, Peddibhotla S, Roth GP, Smith LH, Kipps TJ, Cosford N, Cashman J, et al. Chemical biology strategy reveals pathway-selective inhibitor of NF-kappaB activation induced by protein kinase C. Acs Chemical Biology. 5: 287-99. PMID 20141195 DOI: 10.1021/Cb9003089  0.337
2010 Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R, Dalesandro D, Delaet NG, Erb E, Ernst J, Gibbs A, Kahl J, Kessler L, Lundström J, Miller S, Nakanishi H, et al. KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. European Journal of Pharmacology. 632: 93-102. PMID 20132813 DOI: 10.1016/J.Ejphar.2010.01.011  0.324
2010 De SK, Chen V, Stebbins JL, Chen LH, Cellitti JF, Machleidt T, Barile E, Riel-Mehan M, Dahl R, Yang L, Emdadi A, Murphy R, Pellecchia M. Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors. Bioorganic & Medicinal Chemistry. 18: 590-6. PMID 20045647 DOI: 10.1016/J.Bmc.2009.12.013  0.412
2010 Dahl R, Baldridge KK, Finney NS. Efficient access to aminomannoside derivatives via formal [2+2] cycloaddition of triazolinediones and tri- O -acetyl- D -glucal Synthesis. 2292-2296. DOI: 10.1055/S-0029-1218803  0.579
2009 Dahl R, Sergienko EA, Su Y, Mostofi YS, Yang L, Simao AM, Narisawa S, Brown B, Mangravita-Novo A, Vicchiarelli M, Smith LH, O'Neill WC, Millán JL, Cosford ND. Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). Journal of Medicinal Chemistry. 52: 6919-25. PMID 19821572 DOI: 10.1021/Jm900383S  0.399
2009 Wei J, Kitada S, Rega MF, Stebbins JL, Zhai D, Cellitti J, Yuan H, Emdadi A, Dahl R, Zhang Z, Yang L, Reed JC, Pellecchia M. Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. Journal of Medicinal Chemistry. 52: 4511-23. PMID 19555126 DOI: 10.1021/Jm900472S  0.397
2009 Wei J, Kitada S, Rega MF, Emdadi A, Yuan H, Cellitti J, Stebbins JL, Zhai D, Sun J, Yang L, Dahl R, Zhang Z, Wu B, Wang S, Reed TA, et al. Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins. Molecular Cancer Therapeutics. 8: 904-13. PMID 19372563 DOI: 10.1158/1535-7163.Mct-08-1050  0.368
2009 Wu B, Rega MF, Wei J, Yuan H, Dahl R, Zhang Z, Pellecchia M. Discovery and binding studies on a series of novel Pin1 ligands. Chemical Biology & Drug Design. 73: 369-79. PMID 19291099 DOI: 10.1111/J.1747-0285.2009.00795.X  0.361
2009 De SK, Chen LH, Stebbins JL, Machleidt T, Riel-Mehan M, Dahl R, Chen V, Yuan H, Barile E, Emdadi A, Murphy R, Pellecchia M. Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors. Bioorganic & Medicinal Chemistry. 17: 2712-7. PMID 19282190 DOI: 10.1016/J.Bmc.2009.02.046  0.391
2009 De SK, Stebbins JL, Chen LH, Riel-Mehan M, Machleidt T, Dahl R, Yuan H, Emdadi A, Barile E, Chen V, Murphy R, Pellecchia M. Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase. Journal of Medicinal Chemistry. 52: 1943-52. PMID 19271755 DOI: 10.1021/Jm801503N  0.404
2008 Huang JW, Zhang Z, Wu B, Cellitti JF, Zhang X, Dahl R, Shiau CW, Welsh K, Emdadi A, Stebbins JL, Reed JC, Pellecchia M. Fragment-based design of small molecule X-linked inhibitor of apoptosis protein inhibitors. Journal of Medicinal Chemistry. 51: 7111-8. PMID 18956862 DOI: 10.1021/Jm8006992  0.379
2008 Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R, Dalesandro D, Delaet NG, Erb E, Gibbs A, Kahl J, Kessler L, Lundström J, Miller S, Nakanishi H, Roberts E, et al. 'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 5456-9. PMID 18835164 DOI: 10.1016/J.Bmcl.2008.09.028  0.33
2008 Noberini R, Koolpe M, Peddibhotla S, Dahl R, Su Y, Cosford ND, Roth GP, Pasquale EB. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. The Journal of Biological Chemistry. 283: 29461-72. PMID 18728010 DOI: 10.1074/Jbc.M804103200  0.394
2008 Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R, Dalesandro D, Delaet NG, Erb E, Ernst JT, Gibbs A, Kahl J, Kessler L, Lundström J, Miller S, Nakanishi H, et al. The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 1772-7. PMID 18325768 DOI: 10.1016/J.Bmcl.2008.02.033  0.373
2008 Ernst J, Dahl R, Lum C, Sebo L, Urban J, Miller SG, Lundström J. Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 18: 1498-501. PMID 18194864 DOI: 10.1016/J.Bmcl.2007.12.058  0.314
2007 Johnston PA, Phillips J, Shun TY, Shinde S, Lazo JS, Huryn DM, Myers MC, Ratnikov BI, Smith JW, Su Y, Dahl R, Cosford ND, Shiryaev SA, Strongin AY. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus. Assay and Drug Development Technologies. 5: 737-50. PMID 18181690 DOI: 10.1089/Adt.2007.101  0.345
2007 Abbas S, Bhoumik A, Dahl R, Vasile S, Krajewski S, Cosford ND, Ronai ZA. Preclinical studies of celastrol and acetyl isogambogic acid in melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6769-78. PMID 18006779 DOI: 10.1158/1078-0432.Ccr-07-1536  0.394
2004 Dahl RS, Finney NS. A surprising dipolar cycloaddition provides ready access to aminoglycosides. Journal of the American Chemical Society. 126: 8356-7. PMID 15237974 DOI: 10.1021/Ja0319238  0.594
2001 Dahl RS, Finney NS. Simple glucal-based linker for the immobilization of alcohols on solid support. Journal of Combinatorial Chemistry. 3: 329-31. PMID 11442388  0.521
Show low-probability matches.